{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:50:09Z","timestamp":1774507809514,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1124\/mol.120.119404","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T20:04:43Z","timestamp":1595880283000},"page":"462-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through G\u03b1z as Shown with Bioluminescence Resonance Energy Transfer"],"prefix":"10.1016","volume":"98","author":[{"given":"Miriam E.","family":"Barnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian I.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4305-5111","authenticated-orcid":false,"given":"Jean M.","family":"Bidlack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.120.119404_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/jm00332a001","article-title":"Pentazocine. Strong analgesics and analgesic antagonists in the benzomorphan series","volume":"7","author":"Archer","year":"1964","journal-title":"J Med Chem"},{"key":"10.1124\/mol.120.119404_bib2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/BF02532378","article-title":"Cyclazocine revisited","volume":"21","author":"Archer","year":"1996","journal-title":"Neurochem Res"},{"key":"10.1124\/mol.120.119404_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2164-12-14","article-title":"Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis","volume":"12","author":"Atwood","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1124\/mol.120.119404_bib4","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.120.119404_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0306-4522(97)00623-4","article-title":"Distribution of heterotrimeric G-protein beta and gamma subunits in the rat brain","volume":"85","author":"Betty","year":"1998","journal-title":"Neuroscience"},{"key":"10.1124\/mol.120.119404_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.118.249839","article-title":"In vitro pharmacological characterization of buprenorphine, samidorphan, and combinations being developed as an adjunctive treatment of major depressive disorder","volume":"367","author":"Bidlack","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.120.119404_bib7","first-page":"135","article-title":"Assay of G protein-coupled receptor activation of G proteins in native cell membranes using [35S]GTP gamma S binding","volume":"237","author":"Bidlack","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1124\/mol.120.119404_bib8","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0021-9258(19)39988-0","article-title":"Gz, a guanine nucleotide-binding protein with unique biochemical properties","volume":"265","author":"Casey","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.120.119404_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1101\/pdb.prot098574","article-title":"Using Dounce homogenization to lyse cells for immunoprecipitation","volume":"2019","author":"DeCaprio","year":"2019","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1124\/mol.120.119404_bib10","doi-asserted-by":"crossref","first-page":"2.14.1","DOI":"10.1002\/0471141755.ph0214s70","article-title":"Using Bioluminescence resonance energy transfer (BRET) to characterize agonist-induced arrestin recruitment to modified and unmodified G protein-coupled receptors","volume":"70","author":"Donthamsetti","year":"2015","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1124\/mol.120.119404_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1083\/jcb.1.2.139","article-title":"A method for isolating intact mitochondria and nuclei from the same homogenate, and the influence of mitochondrial destruction on the properties of cell nuclei","volume":"1","author":"Dounce","year":"1955","journal-title":"J Biophys Biochem Cytol"},{"key":"10.1124\/mol.120.119404_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0898-6568(97)00071-5","article-title":"Identification of a GTPase activating protein specific for the heterotrimeric G protein, Gz","volume":"10","author":"Fields","year":"1998","journal-title":"Cell Signal"},{"key":"10.1124\/mol.120.119404_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-3565(24)36563-2","article-title":"Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and G(x\/z) transducer proteins in mouse periaqueductal gray matter","volume":"281","author":"Garz\u00f3n","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.120.119404_bib14","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/sj.npp.1300726","article-title":"The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins","volume":"30","author":"Garz\u00f3n","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.120.119404_bib15","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.83.7.2258","article-title":"Use of specific antibodies to quantitate the guanine nucleotide-binding protein Go in brain","volume":"83","author":"Gierschik","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.120.119404_bib16","doi-asserted-by":"crossref","first-page":"26008","DOI":"10.1074\/jbc.273.40.26008","article-title":"RGSZ1, a Gz-selective regulator of G protein signaling whose action is sensitive to the phosphorylation state of Gzalpha","volume":"273","author":"Glick","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.120.119404_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","article-title":"Structure and dynamics of GPCR signaling complexes","volume":"25","author":"Hilger","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/mol.120.119404_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000014533","article-title":"Structure and function of the pertussis-toxin-insensitive Gz protein","volume":"7","author":"Ho","year":"1998","journal-title":"Biol Signals Recept"},{"key":"10.1124\/mol.120.119404_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/pr.54.3.527","article-title":"Cellular regulation of RGS proteins: modulators and integrators of G protein signaling","volume":"54","author":"Hollinger","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.120.119404_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cellsig.2009.02.017","article-title":"The C-terminus of GRK3 indicates rapid dissociation of G protein heterotrimers","volume":"21","author":"Hollins","year":"2009","journal-title":"Cell Signal"},{"key":"10.1124\/mol.120.119404_bib21","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0896-6273(00)80636-4","article-title":"G protein alpha subunit G alpha z couples neurotransmitter receptors to ion channels in sympathetic neurons","volume":"21","author":"Jeong","year":"1998","journal-title":"Neuron"},{"key":"10.1124\/mol.120.119404_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000186688","article-title":"Molecular mechanisms of go signaling","volume":"17","author":"Jiang","year":"2009","journal-title":"Neurosignals"},{"key":"10.1124\/mol.120.119404_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/abio.1994.1243","article-title":"A method for protein assay in Laemmli buffer","volume":"219","author":"Karlsson","year":"1994","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.120.119404_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.120.119404_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/pr.111.005603","article-title":"The expanding roles of G\u03b2\u03b3 subunits in G protein-coupled receptor signaling and drug action","volume":"65","author":"Khan","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.120.119404_bib26","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.1082348","article-title":"Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma","volume":"300","author":"Lodowski","year":"2003","journal-title":"Science"},{"key":"10.1124\/mol.120.119404_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-2914-6_8","article-title":"Monitoring G protein activation in cells with BRET","volume":"1335","author":"Masuho","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1124\/mol.120.119404_bib28","doi-asserted-by":"crossref","first-page":"ra123","DOI":"10.1126\/scisignal.aab4068","article-title":"Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors","volume":"8","author":"Masuho","year":"2015","journal-title":"Sci Signal"},{"issue":"Suppl 1","key":"10.1124\/mol.120.119404_bib29","first-page":"S46","article-title":"Heterotrimeric G-proteins: a short history","volume":"147","author":"Milligan","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.120.119404_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","article-title":"Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/mol.120.119404_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the \u03b22 adrenergic receptor-Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1124\/mol.120.119404_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000166277","article-title":"Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies","volume":"17","author":"Sadana","year":"2009","journal-title":"Neurosignals"},{"key":"10.1124\/mol.120.119404_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0361-9230(00)00448-2","article-title":"Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia","volume":"54","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1124\/mol.120.119404_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)35065-7","article-title":"Endomorphin-1 and endomorphin-2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice","volume":"291","author":"S\u00e1nchez-Bl\u00e1zquez","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.120.119404_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nmeth.3398","article-title":"Application of BRET to monitor ligand binding to GPCRs","volume":"12","author":"Stoddart","year":"2015","journal-title":"Nat Methods"},{"key":"10.1124\/mol.120.119404_bib36","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1476-5381.2010.00963.x","article-title":"Use of the GTP\u03b3S ([35S]GTP\u03b3S and Eu-GTP\u03b3S) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors","volume":"161","author":"Strange","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.120.119404_bib37","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.jmb.2016.08.002","article-title":"Regulation, signaling, and physiological functions of G-proteins","volume":"428","author":"Syrovatkina","year":"2016","journal-title":"J Mol Biol"},{"key":"10.1124\/mol.120.119404_bib38","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5\u2032-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.120.119404_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0278-5846(82)80130-9","article-title":"U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists","volume":"6","author":"Von Voigtlander","year":"1982","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/mol.120.119404_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1074\/jbc.270.2.503","article-title":"Lipid modifications of trimeric G proteins","volume":"270","author":"Wedegaertner","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.120.119404_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bmcl.2008.10.134","article-title":"Syntheses and opioid receptor binding properties of carboxamido-substituted opioids","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.120.119404_bib42","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.bmcl.2005.02.032","article-title":"Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone","volume":"15","author":"Wentland","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.120.119404_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(95)00963-A","article-title":"Stimulation of cAMP accumulation by the cloned Xenopus melatonin receptor through Gi and Gz proteins","volume":"372","author":"Yung","year":"1995","journal-title":"FEBS Lett"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24010435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24010435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.120.119404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:34:08Z","timestamp":1739961248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24010435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0026895X24010435"],"URL":"https:\/\/doi.org\/10.1124\/mol.120.119404","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through G\u03b1z as Shown with Bioluminescence Resonance Energy Transfer","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.120.119404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}